ClinicalTrials.Veeva

Menu

VLDL-triglyceride Kinetics in Type 2 Diabetes

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Type 2 Diabetes

Treatments

Other: Hyperinsulinemic euglycemic glucose clamp

Study type

Observational

Funder types

Other

Identifiers

NCT01037647
20070028

Details and patient eligibility

About

Type 2 diabetes is associated with diabetic dyslipidemia, which is a major risk factor for coronary heart disease. Triglycerides (TG) and cholesterol are transported in the system of lipoproteins, and the metabolism of these lipids in plasma is closely interrelated. Evidence suggests that increased concentration of very low-density lipoprotein triglyceride (VLDL-TG) is a central pathophysiological feature of the lipid and lipoprotein abnormalities in diabetic dyslipidemia.

The objective of this study was to investigate VLDL-TG kinetics and aspects of peripheral VLDL-TG metabolism, i.e. to what extent VLDL-TG associated fatty acids (FA) are oxidized or deposited in regional adipose tissue, in subjects with type 2 diabetes and healthy controls in the postabsorptive state and during acute hyperinsulinemia using ex-vivo labeled VLDL-TG tracers.

Enrollment

22 patients

Sex

Male

Ages

20 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Exclusion Criteria:

  • Known disease except type 2 diabetes (type 2 diabetic subjects)
  • Smoking
  • Alcohol abuse
  • Prescription medication expect oral antidiabetics (type 2 diabetic subjects)

Trial design

22 participants in 2 patient groups

Type 2 diabetic men
Description:
Men with type 2 diabetes
Treatment:
Other: Hyperinsulinemic euglycemic glucose clamp
Healthy men
Description:
Healthy men
Treatment:
Other: Hyperinsulinemic euglycemic glucose clamp

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems